# Comparison of MTX+Anti-TNF to MTX+Conventional DMARDs in Patients With Early Rheumatoid Arthritis (RA) Who Failed MTX Alone (SWEFOT)

> **NCT00764725** · PHASE4 · COMPLETED · sponsor: **Karolinska Institutet** · enrollment: 487 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** conventional DMARD combination
- **BIOLOGICAL:** MTX plus anti-TNF

## Key facts

- **NCT ID:** NCT00764725
- **Lead sponsor:** Karolinska Institutet
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-12
- **Primary completion:** 2007-04
- **Final completion:** 2008-12
- **Target enrollment:** 487 (ACTUAL)
- **Last updated:** 2008-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00764725

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00764725, "Comparison of MTX+Anti-TNF to MTX+Conventional DMARDs in Patients With Early Rheumatoid Arthritis (RA) Who Failed MTX Alone (SWEFOT)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00764725. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*